Advertisement

Topics

"Amyotrophic lateral sclerosis Epidemiology Forecast 2025 Report Updated" Drugs and Medication Database

09:37 EST 17th February 2019 | BioPortfolio

Here are the most relevant "Amyotrophic lateral sclerosis Epidemiology Forecast 2025 Report Updated" Drugs and Medications that we have found in our database.

More Information about "Amyotrophic lateral sclerosis Epidemiology Forecast 2025 Report Updated" on BioPortfolio

We have published hundreds of Amyotrophic lateral sclerosis Epidemiology Forecast 2025 Report Updated news stories on BioPortfolio along with dozens of Amyotrophic lateral sclerosis Epidemiology Forecast 2025 Report Updated Clinical Trials and PubMed Articles about Amyotrophic lateral sclerosis Epidemiology Forecast 2025 Report Updated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Amyotrophic lateral sclerosis Epidemiology Forecast 2025 Report Updated Companies in our database. You can also find out about relevant Amyotrophic lateral sclerosis Epidemiology Forecast 2025 Report Updated Drugs and Medications on this site too.

Showing "Amyotrophic lateral sclerosis Epidemiology Forecast 2025 Report Updated" Drugs and Medications 1–25 of 53

Probably Relevant

Riluzole [glenmark pharmaceuticals inc., usa]

These highlights do not include all the information needed to use RILUZOLE TABLETS safely and effectively. See full prescribing information for RILUZOLE TABLETS.RILUZOLE tablets, for oral useInitial U.S. Approval: 1995

Possibly Relevant

Riluzole [rising pharmaceuticals, inc.]

These highlights do not include all the information needed to use RILUZOLE safely and effectively. See full prescribing information for RILUZOLE. RILUZOLE tablets, for oral use Initial U.S. Approval: 1995

Rilutek [covis pharma]

These highlights do not include all the information needed to use RILUTEK safely and effectively. See full prescribing information for RILUTEK RILUTEK (riluzole) tablets, for oral useInitial U.S. Approval: 1995

Riluzole [mylan pharmaceuticals inc.]

These highlights do not include all the information needed to use RILUZOLE TABLETS safely and effectively. See full prescribing information for RILUZOLE TABLETS. RILUZOLE tablets, for oral useInitial U.S. Approval: 1995

Riluzole [quinn pharmaceuticals, llc]

These highlights do not include all the information needed to use RILUZOLE TABLETS safely and effectively. See full prescribing information for RILUZOLE TABLETS. RILUZOLE tablets, for oral useInitial U.S. Approval: 1995

Riluzole [apotex corp]

These highlights do not include all the information needed to use RILUZOLE TABLETS safely and effectively. See full prescribing information for RILUZOLE TABLETS.  RILUZOLE tablets, for oral use Initial U.S. Approval: 1995

Riluzole [sun pharmaceutical industries, inc.]

These highlights do not include all the information needed to use RILUZOLE TABLETS safely and effectively. See full prescribing information for RILUZOLE TABLETS. RILUZOLE tablets, for oral use Initial U.S. Approval: 1995

Riluzole [ascend laboratories, llc]

These highlights do not include all the information needed to use RILUZOLE TABLETS safely and effectively. See full prescribing information for RILUZOLE TABLETS.RILUZOLE tablets for oral useInitial U.S. Approval: 1995

Riluzole [american health packaging]

These highlights do not include all the information needed to use RILUZOLE TABLETS safely and effectively. See full prescribing information for RILUZOLE TABLETS. RILUZOLE tablets, for oral use Initial U.S. Approval: 1995

Tiglutik [itf pharma, inc.]

These highlights do not include all the information needed to use TIGLUTIK   safely and effectively. See full prescribing information for TIGLUTIK .       TIGLUTIK ( ri luzole )   oral s uspension   Initial U.S. Approval: 1995

Radicava [mitsubishi tanabe pharma america, inc.]

These highlights do not include all the information needed to use RADICAVA safely and effectively. See full prescribing information for RADICAVA. RADICAVA (edaravone injection), for intravenous useInitial U.S. Approval: 2017

Teriflunomide [amneal pharmaceuticals llc]

These highlights do not include all the information needed to use TERIFLUNOMIDE TABLETS safely and effectively. See full prescribing information for TERIFLUNOMIDE TABLETS.  TERIFLUNOMIDE tablets, for oral use Initial U.S. Approval: 2012

Aubagio [genzyme corp.]

These highlights do not include all the information needed to use AUBAGIO safely and effectively. See full prescribing information for AUBAGIO. AUBAGIO (teriflunomide) tablets, for oral use Initial U.S. Approval: 2012

Dobutamine [hospira, inc.]

DOBUTamine INJECTION, USP

Botox cosmetic [allergan, inc.]

These highlights do not include all the information needed to use BOTOX Cosmetic safely and effectively. See full prescribing information for BOTOX Cosmetic. BOTOX Cosmetic (onabotulinumtoxinA) for injection, for intramuscular use Initial U.S. Approval: 1

Dysport [galderma laboratories, l.p.]

These highlights do not include all the information needed to use DYSPORT safely and effectively. See full prescribing information for DYSPORT DYSPORT (abobotulinumtoxinA) for injection, for intramuscular use Initial U.S. Approval: April 2009

Dysport [ipsen biopharmaceuticals, inc.]

These highlights do not include all the information needed to use DYSPORT safely and effectively. See full prescribing information for DYSPORT. DYSPORT (abobotulinumtoxinA) for injection, for intramuscular use Initial U.S. Approval: 2009

Botox [allergan, inc.]

These highlights do not include all the information needed to use BOTOX   safely and effectively. See full prescribing information for BOTOX. BOTOX (onabotulinumtoxinA) for injection, for intramuscular, intradetrusor, or intradermal use Initial U.S. Appr

Xeomin [merz pharmaceuticals, llc]

These highlights do not include all the information needed to use XEOMIN safely and effectively. See full prescribing information for XEOMIN. XEOMIN (incobotulinumtoxinA) for injection, for intramuscular or intraglandular use Initial U.S. Approval: 2010

Xeomin [merz north america, inc.]

These highlights do not include all the information needed to use XEOMIN safely and effectively. See full prescribing information for XEOMIN. XEOMIN (incobotulinumtoxinA) for injection, for intramuscular use Initial U.S. Approval: 2010

Tysabri [biogen inc.]

These highlights do not include all the information needed to use TYSABRI safely and effectively. See full prescribing information for TYSABRI.TYSABRI (natalizumab) injection, for intravenous useInitial U.S. Approval: 2004

Rebif [emd serono, inc.]

These highlights do not include all the information needed to use REBIF safely and effectively. See full prescribing information for REBIF. REBIF (interferon beta-1a), for subcutaneous injectionInitial U.S. Approval: 1996

Tecfidera [biogen inc.]

These highlights do not include all the information needed to use TECFIDERA safely and effectively. See full prescribing information for TECFIDERA.TECFIDERA (dimethyl fumarate) delayed-release capsules, for oral useInitial U.S. Approval: 2013

Letrozole [breckenridge pharmaceutical, inc.]

These highlights do not include all the information needed to use LETROZOLE TABLETS safely and effectively. See full prescribing information for LETROZOLE TABLETS. LETROZOLE tablets, for oral use Initial U.S. Approval: 1997

Letrozole [sun pharmaceutical industries limited ]

These highlights do not include all the information needed to use LETROZOLE TABLETS safely and effectively. See full prescribing information for LETROZOLE TABLETS. LETROZOLE tablets, for oral use Initial U.S. Approval: 1997



Advertisement
Quick Search
Advertisement
Advertisement